Back to Journals » ImmunoTargets and Therapy » Volume 4

Update on use of aldesleukin for treatment of high-risk metastatic melanoma

Total article views   HTML views PDF downloads Totals
16,580 Dovepress* 12,147+ 2,009 14,156
PubMed Central* 4,433 617 5,050
Totals 16,580 2,626 19,206
*Since 7 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar